222 related articles for article (PubMed ID: 26162980)
21. Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery.
Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
Int J Pharm; 2005 Jul; 298(1):55-67. PubMed ID: 15941634
[TBL] [Abstract][Full Text] [Related]
22. Characterization of 9-nitrocamptothecin-in-cyclodextrin-in-liposomes modified with transferrin for the treating of tumor.
Chen J; Lu S; Gu W; Peng P; Dong J; Xu F; Yang X; Xiong Z; Yang X
Int J Pharm; 2015 Jul; 490(1-2):219-28. PubMed ID: 26004006
[TBL] [Abstract][Full Text] [Related]
23. Investigation of nanostructured lipid carriers for transdermal delivery of flurbiprofen.
Han F; Li S; Yin R; Shi X; Jia Q
Drug Dev Ind Pharm; 2008 Apr; 34(4):453-8. PubMed ID: 18401788
[TBL] [Abstract][Full Text] [Related]
24. Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-beta-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery.
McCormack B; Gregoriadis G
Biochim Biophys Acta; 1996 Dec; 1291(3):237-44. PubMed ID: 8980638
[TBL] [Abstract][Full Text] [Related]
25. Effects of solid carriers on the crystalline properties, dissolution and bioavailability of flurbiprofen in solid self-nanoemulsifying drug delivery system (solid SNEDDS).
Kang JH; Oh DH; Oh YK; Yong CS; Choi HG
Eur J Pharm Biopharm; 2012 Feb; 80(2):289-97. PubMed ID: 22119666
[TBL] [Abstract][Full Text] [Related]
26. PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions.
Vega E; Gamisans F; García ML; Chauvet A; Lacoulonche F; Egea MA
J Pharm Sci; 2008 Dec; 97(12):5306-17. PubMed ID: 18425815
[TBL] [Abstract][Full Text] [Related]
27. Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation.
Chi L; Liu R; Guo T; Wang M; Liao Z; Wu L; Li H; Wu D; Zhang J
Int J Pharm; 2015 Feb; 479(2):349-56. PubMed ID: 25575474
[TBL] [Abstract][Full Text] [Related]
28. Inclusion complexes of bendamustine with β-CD, HP-β-CD and Epi-β-CD: in-vitro and in-vivo evaluation.
Gidwani B; Vyas A
Drug Dev Ind Pharm; 2015; 41(12):1978-88. PubMed ID: 25946905
[TBL] [Abstract][Full Text] [Related]
29. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
30. Combination of β-cyclodextrin inclusion complex and self-microemulsifying drug delivery system for photostability and enhanced oral bioavailability of methotrexate: novel technique.
Bourkaib N; Zhou J; Yao J; Fang Z; Mezghrani O
Drug Dev Ind Pharm; 2013 Jun; 39(6):918-27. PubMed ID: 22998295
[TBL] [Abstract][Full Text] [Related]
31. Cyclodextrins.
Stella VJ; He Q
Toxicol Pathol; 2008 Jan; 36(1):30-42. PubMed ID: 18337219
[TBL] [Abstract][Full Text] [Related]
32. Novel nanoliposomal delivery system for polydatin: preparation, characterization, and in vivo evaluation.
Wang X; Guan Q; Chen W; Hu X; Li L
Drug Des Devel Ther; 2015; 9():1805-13. PubMed ID: 25848217
[TBL] [Abstract][Full Text] [Related]
33. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.
Cirri M; Bragagni M; Mennini N; Mura P
Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833
[TBL] [Abstract][Full Text] [Related]
34. Development of galangal essential oil-based microemulsion gel for transdermal delivery of flurbiprofen: simultaneous permeability evaluation of flurbiprofen and 1,8-cineole.
Dong J; Zhu XM; Wu FY; Yang BQ; Feng H; Dong YF; Gu W; Chen J
Drug Dev Ind Pharm; 2020 Jan; 46(1):91-100. PubMed ID: 31878816
[TBL] [Abstract][Full Text] [Related]
35. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC.
Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
Colloids Surf B Biointerfaces; 2010 Dec; 81(2):412-21. PubMed ID: 20719479
[TBL] [Abstract][Full Text] [Related]
36. Nanostructured lipid carriers-based flurbiprofen gel after topical administration: acute skin irritation, pharmacodynamics, and percutaneous absorption mechanism.
Song A; Su Z; Li S; Han F
Drug Dev Ind Pharm; 2015; 41(9):1488-92. PubMed ID: 25231972
[TBL] [Abstract][Full Text] [Related]
37. Liposomes incorporating cyclodextrin-drug inclusion complexes: Current state of knowledge.
Gharib R; Greige-Gerges H; Fourmentin S; Charcosset C; Auezova L
Carbohydr Polym; 2015 Sep; 129():175-86. PubMed ID: 26050903
[TBL] [Abstract][Full Text] [Related]
38. Single Intravenous Dose of Novel Flurbiprofen-Loaded Proniosome Formulations Provides Prolonged Systemic Exposure and Anti-inflammatory Effect.
Verma P; Prajapati SK; Yadav R; Senyschyn D; Shea PR; Trevaskis NL
Mol Pharm; 2016 Nov; 13(11):3688-3699. PubMed ID: 27632682
[TBL] [Abstract][Full Text] [Related]
39. Development of flurbiprofen-loaded nanoparticles with a narrow size distribution using sucrose.
Oh DH; Yan YD; Kim DW; Kim JO; Yong CS; Choi HG
Drug Dev Ind Pharm; 2014 Feb; 40(2):172-7. PubMed ID: 23600652
[TBL] [Abstract][Full Text] [Related]
40. Niosomes encapsulating Ibuprofen-cyclodextrin complexes: preparation and characterization.
Marianecci C; Rinaldi F; Esposito S; Di Marzio L; Carafa M
Curr Drug Targets; 2013 Aug; 14(9):1070-8. PubMed ID: 23531114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]